Upstream Bio (UPB) Competitors $16.21 -0.40 (-2.41%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends UPB vs. PBH, RNA, OGN, PTCT, PRGO, VRNA, RYTM, MLTX, JANX, and EWTXShould you be buying Upstream Bio stock or one of its competitors? The main competitors of Upstream Bio include Prestige Consumer Healthcare (PBH), Avidity Biosciences (RNA), Organon & Co. (OGN), PTC Therapeutics (PTCT), Perrigo (PRGO), Verona Pharma (VRNA), Rhythm Pharmaceuticals (RYTM), MoonLake Immunotherapeutics (MLTX), Janux Therapeutics (JANX), and Edgewise Therapeutics (EWTX). These companies are all part of the "pharmaceutical preparations" industry. Upstream Bio vs. Prestige Consumer Healthcare Avidity Biosciences Organon & Co. PTC Therapeutics Perrigo Verona Pharma Rhythm Pharmaceuticals MoonLake Immunotherapeutics Janux Therapeutics Edgewise Therapeutics Prestige Consumer Healthcare (NYSE:PBH) and Upstream Bio (NASDAQ:UPB) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, community ranking, earnings, profitability, dividends, valuation, institutional ownership and media sentiment. Does the media prefer PBH or UPB? In the previous week, Prestige Consumer Healthcare had 2 more articles in the media than Upstream Bio. MarketBeat recorded 9 mentions for Prestige Consumer Healthcare and 7 mentions for Upstream Bio. Prestige Consumer Healthcare's average media sentiment score of 1.19 beat Upstream Bio's score of 0.40 indicating that Prestige Consumer Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Prestige Consumer Healthcare 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Upstream Bio 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Is PBH or UPB more profitable? Prestige Consumer Healthcare has a net margin of 18.54% compared to Upstream Bio's net margin of 0.00%. Prestige Consumer Healthcare's return on equity of 12.23% beat Upstream Bio's return on equity.Company Net Margins Return on Equity Return on Assets Prestige Consumer Healthcare18.54% 12.23% 6.14% Upstream Bio N/A N/A N/A Do analysts prefer PBH or UPB? Prestige Consumer Healthcare presently has a consensus price target of $85.25, indicating a potential upside of 8.30%. Upstream Bio has a consensus price target of $56.50, indicating a potential upside of 248.55%. Given Upstream Bio's stronger consensus rating and higher probable upside, analysts plainly believe Upstream Bio is more favorable than Prestige Consumer Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prestige Consumer Healthcare 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Upstream Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of PBH or UPB? 99.9% of Prestige Consumer Healthcare shares are held by institutional investors. 1.6% of Prestige Consumer Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has stronger valuation & earnings, PBH or UPB? Prestige Consumer Healthcare has higher revenue and earnings than Upstream Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrestige Consumer Healthcare$1.11B3.50$209.34M$4.1119.15Upstream Bio$2.21M393.66N/AN/AN/A Does the MarketBeat Community believe in PBH or UPB? Prestige Consumer Healthcare received 486 more outperform votes than Upstream Bio when rated by MarketBeat users. However, 100.00% of users gave Upstream Bio an outperform vote while only 70.50% of users gave Prestige Consumer Healthcare an outperform vote. CompanyUnderperformOutperformPrestige Consumer HealthcareOutperform Votes49070.50% Underperform Votes20529.50% Upstream BioOutperform Votes4100.00% Underperform VotesNo Votes SummaryPrestige Consumer Healthcare beats Upstream Bio on 9 of the 14 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Upstream Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for UPB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPB vs. The Competition Export to ExcelMetricUpstream BioPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$868.81M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E RatioN/A10.5589.7417.16Price / Sales393.66196.061,117.09117.04Price / CashN/A57.1643.1037.86Price / BookN/A5.094.784.78Net IncomeN/A$151.83M$120.31M$225.60M7 Day Performance-19.95%-2.14%-1.92%-1.23%1 Month Performance-10.89%-4.56%13.65%0.46%1 Year PerformanceN/A8.87%28.34%15.24% Upstream Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPBUpstream Bio2.0497 of 5 stars$16.21-2.4%$56.50+248.6%N/A$868.81M$2.21M0.0038High Trading VolumePBHPrestige Consumer Healthcare3.7935 of 5 stars$82.25-0.1%$85.25+3.6%+27.6%$4.06B$1.11B20.02540Analyst UpgradePositive NewsRNAAvidity Biosciences2.1797 of 5 stars$33.54+3.2%$63.60+89.6%+250.4%$4.00B$10.12M-11.28190Analyst ForecastInsider TradeAnalyst RevisionNews CoverageOGNOrganon & Co.4.8039 of 5 stars$14.74-3.7%$21.33+44.7%+7.2%$3.80B$6.26B2.9110,000PTCTPTC Therapeutics3.6564 of 5 stars$47.89+3.3%$54.08+12.9%+62.7%$3.69B$900.66M-8.041,410Analyst DowngradePRGOPerrigo4.9867 of 5 stars$26.79-2.4%$37.00+38.1%-18.0%$3.65B$4.66B-23.469,140Positive NewsVRNAVerona Pharma0.8479 of 5 stars$42.55+2.7%$43.83+3.0%+156.7%$3.46B$460,000.00-22.2730Positive NewsRYTMRhythm Pharmaceuticals4.1095 of 5 stars$55.26+0.0%$63.70+15.3%+24.3%$3.40B$77.43M-12.76140Analyst ForecastNews CoveragePositive NewsMLTXMoonLake Immunotherapeutics1.6235 of 5 stars$52.20+1.7%$79.88+53.0%-11.0%$3.34BN/A-40.842JANXJanux Therapeutics3.6708 of 5 stars$61.69+0.9%$89.90+45.7%+466.0%$3.24B$13.05M-52.2330EWTXEdgewise Therapeutics2.722 of 5 stars$33.69+22.0%$42.33+25.7%+234.9%$3.19BN/A-22.8560Analyst ForecastAnalyst RevisionHigh Trading Volume Related Companies and Tools Related Companies PBH Alternatives RNA Alternatives OGN Alternatives PTCT Alternatives PRGO Alternatives VRNA Alternatives RYTM Alternatives MLTX Alternatives JANX Alternatives EWTX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:UPB) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Upstream Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Upstream Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UPB Stock Alerts